Arena’s FDA-Approved Weight Loss Pill Clears DEA Hurdle

Arena Pharmaceuticals Inc.’s Belviq, the weight-loss pill approved in June by the U.S. Food and Drug Administration, was cleared to start sales next month after a separate review found the drug’s abuse potential to be low.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.